We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Use of Antibiotics in Preterm Newborns.
- Authors
Simeoli, Raffaele; Cairoli, Sara; Decembrino, Nunzia; Campi, Francesca; Dionisi Vici, Carlo; Corona, Alberto; Goffredo, Bianca Maria
- Abstract
Due to complex maturational and physiological changes that characterize neonates and affect their response to pharmacological treatments, neonatal pharmacology is different from children and adults and deserves particular attention. Although preterms are usually considered part of the neonatal population, they have physiological and pharmacological hallmarks different from full-terms and, therefore, need specific considerations. Antibiotics are widely used among preterms. In fact, during their stay in neonatal intensive care units (NICUs), invasive procedures, including central catheters for parental nutrition and ventilators for respiratory support, are often sources of microbes and require antimicrobial treatments. Unfortunately, the majority of drugs administered to neonates are off-label due to the lack of clinical studies conducted on this special population. In fact, physiological and ethical concerns represent a huge limit in performing pharmacokinetic (PK) studies on these subjects, since they limit the number and volume of blood sampling. Therapeutic drug monitoring (TDM) is a useful tool that allows dose adjustments aiming to fit plasma concentrations within the therapeutic range and to reach specific drug target attainment. In this review of the last ten years' literature, we performed Pubmed research aiming to summarize the PK aspects for the most used antibiotics in preterms.
- Subjects
NEONATAL intensive care units; DRUG monitoring; DRUG therapy; ANTIBIOTICS; NEWBORN infants
- Publication
Antibiotics (2079-6382), 2022, Vol 11, Issue 9, p1142
- ISSN
2079-6382
- Publication type
Article
- DOI
10.3390/antibiotics11091142